A Researcher's Optimism About Myeloma
More treatments for multiple myeloma than ever before are becoming available. Now the challenge is how to optimize treatment for each patient, whether they are young or old, before or after transplant. Dr. Jesús San Miguel is a world renowned myeloma specialist from Salmanca, Spain. In this interview, he describes his optimism for patients today and the strategy for using new combinations of treatments to keep myeloma well managed until researchers can find a cure.
Experts & Guests
Jesús F. San Miguel, M.D., Ph.D.
Head, Hematology Department, Hospital Universitario de Salamanca and Centro de Investigación del CáncerDr. San Miguel is a member of the Advisory Board of the International Myeloma Foundation and a board member of the Spanish Hematology Foundation, the Genome Foundation, and the Spanish Myeloma Group (for which he is also former chairman). He is also National Councilor at the International Society of Hematology and Board Councilor of the European Hematology Association, and he... more >